company background image

Clover ASX:CLV Stock Report

Last Price


Market Cap







29 Sep, 2022


Company Financials +
CLV fundamental analysis
Snowflake Score
Future Growth4/6
Past Performance2/6
Financial Health5/6

CLV Stock Overview

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas.

Clover Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Clover
Historical stock prices
Current Share PriceAU$1.30
52 Week HighAU$1.80
52 Week LowAU$0.95
1 Month Change17.73%
3 Month Change25.12%
1 Year Change-16.45%
3 Year Change-56.83%
5 Year Change194.32%
Change since IPO270.00%

Recent News & Updates

Sep 17
Clover's (ASX:CLV) Dividend Will Be A$0.01

Clover's (ASX:CLV) Dividend Will Be A$0.01

Clover Corporation Limited ( ASX:CLV ) will pay a dividend of A$0.01 on the 22nd of November. The dividend yield is...

Jun 07
Here's Why Clover (ASX:CLV) Can Manage Its Debt Responsibly

Here's Why Clover (ASX:CLV) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Shareholder Returns

CLVAU ChemicalsAU Market

Return vs Industry: CLV underperformed the Australian Chemicals industry which returned -7.9% over the past year.

Return vs Market: CLV underperformed the Australian Market which returned -12.6% over the past year.

Price Volatility

Is CLV's price volatile compared to industry and market?
CLV volatility
CLV Average Weekly Movement8.1%
Chemicals Industry Average Movement11.0%
Market Average Movement9.6%
10% most volatile stocks in AU Market16.8%
10% least volatile stocks in AU Market4.2%

Stable Share Price: CLV is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: CLV's weekly volatility (8%) has been stable over the past year.

About the Company

198853Peter Davey

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications.

Clover Fundamentals Summary

How do Clover's earnings and revenue compare to its market cap?
CLV fundamental statistics
Market CapAU$217.20m
Earnings (TTM)AU$5.50m
Revenue (TTM)AU$60.79m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CLV income statement (TTM)
Cost of RevenueAU$42.39m
Gross ProfitAU$18.39m
Other ExpensesAU$12.89m

Last Reported Earnings

Jan 31, 2022

Next Earnings Date


Earnings per share (EPS)0.033
Gross Margin30.26%
Net Profit Margin9.05%
Debt/Equity Ratio20.4%

How did CLV perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio

Does CLV pay a reliable dividends?

See CLV dividend history and benchmarks
When do you need to buy CLV by to receive an upcoming dividend?
Clover dividend dates
Ex Dividend DateOct 25 2022
Dividend Pay DateNov 22 2022
Days until Ex dividend26 days
Days until Dividend pay date54 days

Does CLV pay a reliable dividends?

See CLV dividend history and benchmarks
We’ve recently updated our valuation analysis.


Is CLV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLV?

Other financial metrics that can be useful for relative valuation.

CLV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.7x
Enterprise Value/EBITDA24.5x
PEG Ratio1.4x

Price to Earnings Ratio vs Peers

How does CLV's PE Ratio compare to its peers?

CLV PE Ratio vs Peers
The above table shows the PE ratio for CLV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average32.7x
ANO Advance ZincTek
BRL Bathurst Resources
CEL Challenger Exploration
CLV Clover

Price-To-Earnings vs Peers: CLV is expensive based on its Price-To-Earnings Ratio (39.2x) compared to the peer average (32.7x).

Price to Earnings Ratio vs Industry

How does CLV's PE Ratio compare vs other companies in the Global Chemicals Industry?

Price-To-Earnings vs Industry: CLV is expensive based on its Price-To-Earnings Ratio (39.2x) compared to the Global Chemicals industry average (14.3x)

Price to Earnings Ratio vs Fair Ratio

What is CLV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio39.2x
Fair PE Ratio20.9x

Price-To-Earnings vs Fair Ratio: CLV is expensive based on its Price-To-Earnings Ratio (39.2x) compared to the estimated Fair Price-To-Earnings Ratio (20.9x).

Share Price vs Fair Value

What is the Fair Price of CLV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLV (A$1.3) is trading above our estimate of fair value (A$0.43)

Significantly Below Fair Value: CLV is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Clover forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score


Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLV's forecast earnings growth (27.4% per year) is above the savings rate (1.8%).

Earnings vs Market: CLV's earnings (27.4% per year) are forecast to grow faster than the Australian market (6.6% per year).

High Growth Earnings: CLV's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CLV's revenue (15.4% per year) is forecast to grow faster than the Australian market (3.6% per year).

High Growth Revenue: CLV's revenue (15.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CLV's Return on Equity is forecast to be low in 3 years time (15.3%).

Discover growth companies

Past Performance

How has Clover performed over the past 5 years?

Past Performance Score


Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CLV has high quality earnings.

Growing Profit Margin: CLV's current net profit margins (9%) are lower than last year (12.9%).

Past Earnings Growth Analysis

Earnings Trend: CLV's earnings have grown by 12.2% per year over the past 5 years.

Accelerating Growth: CLV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CLV had negative earnings growth (-46.9%) over the past year, making it difficult to compare to the Chemicals industry average (20.9%).

Return on Equity

High ROE: CLV's Return on Equity (9.3%) is considered low.

Discover strong past performing companies

Financial Health

How is Clover's financial position?

Financial Health Score


Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CLV's short term assets (A$54.5M) exceed its short term liabilities (A$7.9M).

Long Term Liabilities: CLV's short term assets (A$54.5M) exceed its long term liabilities (A$11.5M).

Debt to Equity History and Analysis

Debt Level: CLV's net debt to equity ratio (7%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if CLV's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CLV's debt is well covered by operating cash flow (27.3%).

Interest Coverage: CLV's interest payments on its debt are well covered by EBIT (20.6x coverage).

Balance Sheet

Discover healthy companies


What is Clover current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Upcoming Dividend Payment

TodaySep 29 2022Ex Dividend DateOct 25 2022Dividend Pay DateNov 22 202228 days from Ex DividendBuy in the next 26 days to receive the upcoming dividend

Dividend Yield vs Market

Clover Dividend Yield vs Market
How does Clover dividend yield compare to the market?
SegmentDividend Yield
Company (Clover)1.5%
Market Bottom 25% (AU)2.8%
Market Top 25% (AU)7.2%
Industry Average (Chemicals)2.9%
Analyst forecast in 3 Years (Clover)1.5%

Notable Dividend: CLV's dividend (1.54%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.8%).

High Dividend: CLV's dividend (1.54%) is low compared to the top 25% of dividend payers in the Australian market (7.19%).

Stability and Growth of Payments

Stable Dividend: CLV is not paying a notable dividend for the Australian market, therefore no need to check if payments are stable.

Growing Dividend: CLV is not paying a notable dividend for the Australian market, therefore no need to check if payments are increasing.

Earnings Payout to Shareholders

Earnings Coverage: CLV is not paying a notable dividend for the Australian market.

Cash Payout to Shareholders

Cash Flow Coverage: CLV is not paying a notable dividend for the Australian market.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Peter Davey





Mr. Peter J. Davey, MBA, GradDip Bus., Dip Art(Design), GAICD, has been Chief Executive Officer and Managing Director of Clover Corporation Limited since November 11, 2014. Mr. Davey has held senior manage...

CEO Compensation Analysis

Peter Davey's Compensation vs Clover Earnings
How has Peter Davey's remuneration changed compared to Clover's earnings?
DateTotal Comp.SalaryCompany Earnings
Jan 31 2022n/an/a


Oct 31 2021n/an/a


Jul 31 2021n/an/a


Apr 30 2021n/an/a


Jan 31 2021n/an/a


Oct 31 2020n/an/a


Jul 31 2020AU$952kAU$441k


Apr 30 2020n/an/a


Jan 31 2020n/an/a


Oct 31 2019n/an/a


Jul 31 2019AU$2mAU$417k


Apr 30 2019n/an/a


Jan 31 2019n/an/a


Oct 31 2018n/an/a


Jul 31 2018AU$1mAU$394k


Apr 30 2018n/an/a


Jan 31 2018n/an/a


Oct 31 2017n/an/a


Jul 31 2017AU$475kAU$346k


Apr 30 2017n/an/a


Jan 31 2017n/an/a


Oct 31 2016n/an/a


Jul 31 2016AU$408kAU$341k


Compensation vs Market: Peter's total compensation ($USD430.22K) is above average for companies of similar size in the Australian market ($USD272.76K).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: CLV's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

Experienced Board: CLV's board of directors are considered experienced (6.3 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: CLV insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

ASX:CLV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Sep 22BuyAU$10,445Toni BrendishIndividual9,900AU$1.06
14 Sep 22BuyAU$10,954Simon GreenIndividual10,000AU$1.10
19 Jul 22BuyAU$2,835,042Perpetual LimitedCompany2,206,270AU$1.68
19 Jul 22SellAU$493,342Perpetual LimitedCompany436,730AU$1.40

Ownership Breakdown

What is the ownership structure of CLV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders6,226,1503.7%
Private Companies10,327,0006.2%
Public Companies50,566,86730.4%
General Public85,199,17451.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 48.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
Washington H. Soul Pattinson and Company Limited
33,926,867A$43.9m0%no data
Thai Union Group Public Company Limited
16,640,000A$21.5m0%no data
Perpetual Limited
Evelin Investments Pty Ltd.
7,550,000A$9.8m0%no data
A V Incani & Papadopoulos Pty Ltd
2,010,000A$2.6m0%no data
Peter Howells
1,500,000A$1.9m0%no data
Dimensional Fund Advisors LP
1,136,795A$1.5m0.03%no data
Garrie Ellice
1,020,000A$1.3m0%no data
Pei Foo
900,000A$1.2m0%no data
Nina Tschernykow
858,881A$1.1m0%no data
Connaught Consultants Finance Pty Ltd.
767,000A$993.3k0%no data
Leslie Szekely
719,600A$931.9k0%no data
Zurich Investment Management Limited
Rupert Harrington
528,921A$685.0k0%no data
Peter Davey
525,459A$680.5k0%no data
Bonafide Wealth Management AG
Sumitomo Mitsui DS Asset Management Company, Limited
220,000A$284.9k0%no data
State Street Global Advisors, Inc.
69,375A$89.8k0.9%no data
Celeste Funds Management Limited
Ian Glasson
60,000A$77.7k0%no data
Graeme Billings
50,000A$64.8k0%no data
Simon Green
36,234A$46.9k38.12%no data
Toni Brendish
27,055A$35.0k57.71%no data

Company Information

Clover Corporation Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Clover Corporation Limited
  • Ticker: CLV
  • Exchange: ASX
  • Founded: 1988
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Implied Market Cap: AU$217.203m
  • Shares outstanding: 166.44m
  • Website:

Number of Employees


  • Clover Corporation Limited
  • 39 Pinnacle Road
  • Altona North
  • Victoria
  • 3025
  • Australia


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CLVASX (Australian Securities Exchange)YesOrdinary SharesAUAUDNov 1999
CLVCHIA (Chi-X Australia)YesOrdinary SharesAUAUDNov 1999

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/29 00:00
End of Day Share Price2022/09/29 00:00
Annual Earnings2021/07/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.